Lotronex Advisers to the U.S. Food and Drug Administration say the agency should reverse its decision to ban a drug used to treat chronic diarrhea caused by irritable bowel syndrome. Lotronex was taken off the market 18 months ago after it was linked to serious intestinal problems. NPR's Joanne Silberner reports that since then, patients have been pushing to bring back Lotronex, despite its risks.
NPR logo

Lotronex

  • Download
  • <iframe src="https://www.npr.org/player/embed/1142286/142286" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Lotronex

Lotronex

Lotronex

  • Download
  • <iframe src="https://www.npr.org/player/embed/1142286/142286" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Advisers to the U.S. Food and Drug Administration say the agency should reverse its decision to ban a drug used to treat chronic diarrhea caused by irritable bowel syndrome. Lotronex was taken off the market 18 months ago after it was linked to serious intestinal problems. NPR's Joanne Silberner reports that since then, patients have been pushing to bring back Lotronex, despite its risks.